Loading…
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $301M | $39M | $-10M | $32M | -15.6% | -10.0% | - |
| 2024 | $334M | $15M | $-29M | $9M | -56.2% | -16.0% | - |
| 2023 | $398M | $-54M | $-100M | $9M | -168.6% | 8.8% | -326.4% |
| 2022 | $366M | $82M | $44M | $-124M | 26.5% | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total Revenue | 365.88 | 397.99 | 334.29 | 300.79 |
| Cost Of Revenue | 117.10 | 242.88 | 152 | 104.43 |
| Gross Profit | 248.78 | 155.11 | 182.30 | 196.36 |
| Operating Expense | 274.62 | 286.03 | 250.07 | 217.17 |
| Operating Income | -25.84 | -130.92 | -67.77 | -20.80 |
| EBITDA | 81.60 | -53.56 | 14.54 | 38.74 |
| EBIT | 58.73 | -88.24 | -19.14 | 13.39 |
| Pretax Income | 45.34 | -101.89 | -29.55 | -5.94 |
| Tax Provision | 1.11 | -1.77 | -0.45 | 3.58 |
| Net Income | 44.22 | -100.12 | -29.10 | -9.52 |
| Net Income Common Stockholders | 44.22 | -100.12 | -29.10 | -9.52 |
| Total Expenses | 391.72 | 528.91 | 402.07 | 321.59 |
| Interest Expense | 13.39 | 13.65 | 10.41 | 19.33 |
| Interest Income | 9.18 | 23.17 | 16.64 | 8.95 |
| Research And Development | 8.44 | 10.10 | 6.30 | 5.63 |
| Selling General And Administration | 266.18 | 275.93 | 243.77 | 211.54 |
| Normalized EBITDA | 4.56 | -67.87 | 16.11 | 32.43 |
| Normalized Income | -30.97 | -114.17 | -27.55 | -14.50 |
| Basic EPS | 0.30 | -0.76 | -0.23 | -0.08 |
| Diluted EPS | 0.23 | -0.76 | -0.23 | -0.16 |
| Tax Effect Of Unusual Items | 1.85 | 0.25 | -0.02 | 1.32 |
| Tax Rate For Calcs | 0.02 | 0.02 | 0.01 | 0.21 |
| Total Unusual Items | 77.05 | 14.30 | -1.57 | 6.31 |
| Total Unusual Items Excluding Goodwill | 77.05 | 14.30 | -1.57 | 6.31 |
| Net Income From Continuing Operation Net Minority Interest | 44.22 | -100.12 | -29.10 | -9.52 |
| Reconciled Depreciation | 22.87 | 34.67 | 33.68 | 25.35 |
| Reconciled Cost Of Revenue | 117.10 | 242.88 | 152 | 104.43 |
| Net Interest Income | -4.22 | 9.52 | 6.23 | -10.37 |
| Net Income From Continuing And Discontinued Operation | 44.22 | -100.12 | -29.10 | -9.52 |
| Total Operating Income As Reported | -25.84 | -130.92 | -67.77 | -20.80 |
| Diluted Average Shares | 148.51 | 131.68 | 123.83 | 135.80 |
| Basic Average Shares | 147.55 | 131.68 | 123.83 | 126.38 |
| Diluted NI Availto Com Stockholders | -34.12 | -100.12 | -51.77 | -22.11 |
| Average Dilution Earnings | -78.34 | 0 | -22.67 | -12.59 |
| Net Income Including Noncontrolling Interests | 44.22 | -100.12 | -29.10 | -9.52 |
| Net Income Continuous Operations | 44.22 | -100.12 | -29.10 | -9.52 |
| Other Income Expense | 75.40 | 19.50 | 31.99 | 25.24 |
| Other Non Operating Income Expenses | -1.65 | 5.20 | 33.56 | 18.93 |
| Gain On Sale Of Security | 77.05 | 14.30 | -1.57 | 6.31 |
| Net Non Operating Interest Income Expense | -4.22 | 9.52 | 6.23 | -10.37 |
| Interest Expense Non Operating | 13.39 | 13.65 | 10.41 | 19.33 |
| Interest Income Non Operating | 9.18 | 23.17 | 16.64 | 8.95 |
| Selling And Marketing Expense | 160.08 | 144.50 | 118.31 | 93.59 |
| General And Administrative Expense | 106.10 | 131.43 | 125.46 | 117.95 |
| Other Gand A | 106.10 | 131.43 | 125.46 | 117.95 |
| Operating Revenue | 365.88 | 397.99 | 334.29 | 300.79 |
Consumer Defensive sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| SkinHealth Systems Inc.this co. | SKIN | $104M | - | 1.68 | -15.6% | 55.16 |
| BRC Inc. | BRCC | $128M | - | 2.77 | -17.5% | -18.14 |
| HF Foods Group Inc. | HFFG | $103M | - | 0.51 | -19.1% | 9.29 |
| Waldencast plc | WALD | $98M | - | 0.20 | -45.9% | -42.73 |
| Solesence, Inc. | SLSN | $92M | 65.00 | 5.20 |
| 10.2% |
| 46.52 |
| Zevia PBC | ZVIA | $90M | - | 1.65 | -27.9% | -5.05 |
| FitLife Brands, Inc. | FTLF | $87M | 14.70 | 1.99 | 14.5% | 9.60 |
| Ispire Technology Inc. | ISPR | $76M | - | -9.85 | -6489.3% | -1.88 |
| LifeVantage Corporation | LFVN | $65M | 8.42 | 1.96 | 28.3% | 5.53 |
| Peer Median | - | 14.70 | 1.81 | -18.3% | 1.83 | |